糖尿病、多囊肾病或晚期肝病患者的腹膜透析管理
本文综述了糖尿病、多囊肾病和慢性肝病三种合并症对腹膜透析(PD)实施的影响及PD对这些疾病的影响。糖尿病者需关注透析液葡萄糖吸收对代谢和容量管理的影响,多囊肾病者需限制腹腔内压,肝病者需营养支持并管理腹水、感染和疝风险。总体而言,PD在这类患者中的选择应基于医患共同决策。
要点
- 糖尿病PD患者应通过肾脏与糖尿病专家多学科团队管理代谢和容量。
- 多囊肾病PD处方需重点关注限制增大的多囊肾与透析液共同所致的腹腔内压升高。
- 肝病PD患者需营养支持以补充蛋白质丢失,并谨慎管理腹水、感染、疝和渗漏风险。
核心结论
- 糖尿病、多囊肾病和慢性肝病合并症患者使用PD需理解疾病对PD实施的影响及PD对疾病本身的影响。
- 在这些合并症患者中选择PD应基于与患者及家属的共同决策,并提供清晰的风险、获益和管理策略信息。
研究设计与样本
- 本文为综述,回顾了糖尿病、多囊肾病和慢性肝病三种合并症与腹膜透析相互影响的临床管理要点。
主要发现
- 糖尿病PD患者透析液葡萄糖吸收会复杂化代谢控制并影响盐和水管理及患者结局。
- 多囊肾病PD患者因增大的多囊器官与透析液共同作用可能增加腹腔内压,处方需重点限制该压力。
- 肝病PD患者PD可加重肝病本身所致的蛋白质丢失,需营养支持并谨慎管理腹水、感染、疝和渗漏风险。
- 肝病PD患者死亡率高,但在低血压、凝血异常或难治性腹水等情况下PD可能优于血液透析。
临床怎么用
- 糖尿病PD患者建议由肾脏和糖尿病专家共同参与的多学科团队提供临床照护。
- 多囊肾病PD处方应特别关注限制腹腔内压升高。
- 肝病PD患者需考虑营养支持以补充蛋白质丢失,并采取审慎方法管理腹水、降低感染风险及疝和渗漏发生。
- 对合并低血压、凝血异常或难治性腹水的肝病患者,PD可能较血液透析是更好的管理选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
People treated with peritoneal dialysis (PD) often have complicating conditions that require careful management. Three such conditions are reviewed in this article-diabetes mellitus, polycystic kidney disease, and chronic liver disease. Each of these conditions requires an understanding of both its effect on the delivery of the PD and the effect of the PD on the condition itself. In diabetes, glucose absorption from the dialysate complicates metabolic control and affects salt and water management and patient outcome. There is particular benefit in clinical care being delivered through a multidisciplinary team that involves both kidney and diabetes experts. In relation to polycystic kidney disease, a key issue is the potential for increased intraperitoneal pressure due to the combined effect of the enlarged polycystic organs and the presence of the dialysis solution, and therefore, the PD prescription requires to be managed with a particular focus on limiting that pressure. For patients with liver disease, key issues include nutritional support because PD can add to protein losses already consequent on the liver disease itself. Considered approaches are required to manage ascites and reduce infection risk and the potential for hernias and leaks to develop. Mortality in this group is unfortunately high-however, PD may present a better management option than hemodialysis in many patients-particularly in those where the liver disease is complicated by low BP, clotting abnormalities, or troublesome ascites. Overall, the choice to use PD in patients with these complicating conditions should be based on shared decision making with the patient and their family members informed by high-quality information in which risks, benefits, and management strategies are clearly presented.
引用
- Agarwal S, Gillis L, Wilkie M, et al. Peritoneal Dialysis Care for People with Diabetes, Polycystic Kidney Disease, or Advanced Liver Disease. Clin J Am Soc Nephrol. 2024. PMID: 38190135. doi:10.2215/CJN.0000000000000420
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。